酚类是一大类化合物,它们主要特征是分子中含有一个羟基(-OH)直接连接在苯环上。这类化合物广泛存在于自然界中,并且具有重要的生物、医药及工业应用价值。
结构与分类酚类化合物的基本结构为苯环上的氧原子与羟基相连。根据羟基的位置不同,可将酚分为单酚和多酚两大类:
酚类可以通过多种途径制备:
尽管酚类化合物具有广泛的应用前景,但它们也可能带来毒性问题。例如强酸性的酚类物质会对皮肤造成刺激甚至腐蚀。因此在使用时需注意安全防护措施。
以上是对酚类的简单介绍,涵盖了其基本定义、生物学意义及工业应用等方面的内容。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 4-bromo-2-[(5S)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 4-bromo-2-[(2R)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | 4-bromo-2-[(5R)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 4-bromo-2-[(3S)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 5-bromo-2-[(7S)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 5-bromo-2-[(3S)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-4-[(5S)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-4-[(5R)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-6-[(7S)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 4-bromo-2-[(3R)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-6-[(3S)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-4-[(7S)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(2R)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | N-(1,3-benzodioxol-5-ylmethyl)-3-chloro-4-hydroxy-5-methoxy-N-methylbenzamide | —— | C17H16ClNO5 |
|
—— | 2-bromo-6-[(2S)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-4-[(3R)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 5-bromo-2-[(2S)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(3S)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 4-bromo-2-[(7S)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-6-[(3R)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(2S)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(3R)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-6-[(5S)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(5S)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-4-[(3S)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-6-[(5R)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 5-bromo-2-[(5S)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 5-bromo-2-[(2R)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(7S)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 5-bromo-2-[(3R)-1,4-oxazepan-3-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-4-[(2R)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(5R)-1,4-oxazepan-5-yl]phenol | —— | C11H14BrNO2 |
|
—— | 3-bromo-4-[(7R)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-4-[(7R)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 2-bromo-6-[(7R)-1,4-oxazepan-7-yl]phenol | —— | C11H14BrNO2 |
|
—— | 4-bromo-2-[(2S)-1,4-oxazepan-2-yl]phenol | —— | C11H14BrNO2 |
|
—— | N-[(2-bromo-4-hydroxyphenyl)methyl]-N-hydroxyacetamide | —— | C9H10BrNO3 |
|
—— | N-[(3-bromo-4-hydroxyphenyl)methyl]-N-hydroxyacetamide | —— | C9H10BrNO3 |
|
—— | N-[(3-bromo-2-hydroxyphenyl)methyl]-N-hydroxyacetamide | —— | C9H10BrNO3 |
|
—— | N-[(4-bromo-2-hydroxyphenyl)methyl]-N-hydroxyacetamide | —— | C9H10BrNO3 |
|
—— | N-[(5-bromo-2-hydroxyphenyl)methyl]-N-hydroxyacetamide | —— | C9H10BrNO3 |
|
—— | (E)-3-[1-[(2-chlorophenyl)methyl]-3,5-dimethylpyrazol-4-yl]-1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one | —— | C22H21ClN2O3 |
|
—— | methyl 2-[(2E,5E)-2,5-bis[(4-hydroxyphenyl)methylidene]cyclopentylidene]-2-cyanoacetate | —— | C23H19NO4 |
|
—— | ethyl (2Z)-2-[(5Z)-3-[2-(diethylamino)-2-oxoethyl]-5-[(3-hydroxyphenyl)methylidene]-4-oxo-1,3-thiazolidin-2-ylidene]acetate | —— | C20H24N2O5S |
|
—— | (E)-3-(1-benzyl-5-chloro-3-methylpyrazol-4-yl)-1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one | —— | C21H19ClN2O3 |
|
—— | (E)-3-(1-benzyl-3,5-dimethylpyrazol-4-yl)-1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one | —— | C22H22N2O3 |
|
—— | (E)-3-[5-(1,3-benzothiazol-2-yl)furan-2-yl]-1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one | —— | C21H15NO4S |
|
—— | (E)-3-[5-chloro-1-[(3S)-1,1-dioxothiolan-3-yl]-3-methylpyrazol-4-yl]-1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one | —— | C18H19ClN2O5S |
|
—— | 4-ethyl-2-[(phenylmethoxyamino)methyl]phenol | —— | C16H19NO2 |
|
—— | ethyl (2Z)-2-[(5Z)-5-[(4-hydroxy-3,5-dimethylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-ylidene]acetate | —— | C16H17NO3S2 |
|